Skip to main content
. 2010 Feb;51(2):844–849. doi: 10.1167/iovs.09-3875

Table 4.

Clinical Features of Patients with DE Stratified by Severity

Severity Level n Symptom Severity Score* Schirmer 1 Score (mm) Conjunctival Staining Score† Corneal Staining Score‡ Corneal Subepithelial Fibrosis§ Meibomian Gland Orifice Metaplasia‖ FCT¶
1 8 30.5 ± 11.2 18 ± 12 0.25 ± 0.46 0.75 ± 1 0.57 ± 0.53 0.71 ± 0.48 4.25 ± 1.13
P < 0.0011,4,5 P < 0.0011
2 16 32.6 ± 10.3 14 ± 12 1.5 ± 2.3 3.6 ± 2 0.25 ± 0.44 0.62 ± 0.5 4.16 ± 1.5
P < 0.0011 P < 0.0011 P < 0.001a,d P < 0.0011
3 7 36.3 ± 13.5 9 ± 8 2.3 ± 2.14 9.3 ± 1.5 0.7 ± 0.4 0.14 ± 0.41 3.43 ± 1.66
P < 0.0011 P < 0.0011,2,3
4 4 41 ± 10.0 4.8 ± 1.3 5.63 ± 0.75 13.7 ± 2.3 0.25 ± 0.5 0 ± 0 5.5 ± 0.41
P < 0.0011 P < 0.0051,2,3,4 P < 0.0011,2,4 P < 0.0011
Control 17 11.9 ± 2.3 27.0 ± 7.8 0 ± 0.0 0 ± 0.0 0 ± 0.0 0 ± 0.0 1.5 ± 0.7

Control, normal control group. The mean score of both eyes was used for the Schirmer 1 test, corneal fluorescein staining. conjunctival staining scores, and BCVA. P, 1vs. control; 2vs. level 1; 3vs. level 2; 4vs. level 3; and 5vs. level 4. Symboled footnotes are described in Table 3.